| Name | Tissue cell type | Category treatment | Timepoint design |
|---|
| AoSMC response to FGF2 | Aortic smooth muscle | Differentiation | Early focus |
| AoSMC response to IL1b | Aortic smooth muscle | Activation | Early focus |
| ES to cardiomyocyte | ES>>cardiomyocyte | Differentiation | Staged in-vitro diff |
| Embryoid body to melanocyte | ES>>melanocytes | Differentiation | Staged in-vitro diff |
| Epithelial to mesenchymal | Epithelial>>mesenchymal cells | Differentiation | Early focus |
| Human iPS to neuron (Down's syndrome) 1 | iPS>>neuron | Differentiation | Staged in-vitro diff |
| Human iPS to neuron (Down's syndrome) 2 | iPS>>neuron | Differentiation | Staged in-vitro diff |
| Human iPS to neuron (wt) 1 | iPS>>neuron | Differentiation | Staged in-vitro diff |
| Human iPS to neuron (wt) 2 | iPS>>neuron | Differentiation | Staged in-vitro diff |
| Lymphatic EC response to VEGFC | Lymphatic endothelial cells | Activation | Early focus |
| MCF7 response to EGF | Breast epithelia cells | Activation | Early focus |
| MCF7 response to HRG | Breast epithelia cells | Differentiation | Early focus |
| MSC to adipocyte (human) | Mesenchymal>>adipose | Differentiation | Early focus |
| Macrophage influenza infection | Monocytes | Activation/ infection | Activation |
| Macrophage response to LPS | Macrophage | Activation | Early focus |
| Myoblast to myotube (wt and DMD) | Myoblast>>myotube | Differentiation | Staged in-vitro diff |
| Preadipocyte to adipocyte | Preadipocyte>>adipocyte | Differentiation | Staged in-vitro diff |
| Rinderpest infection series | T-cells | Activation/ infection | Activation |
| Saos calcification | Osteoblast | differentiation | Early focus |
